GastroAGI Logo
OverviewBlogsAbout
Trending TopicsDaily BriefConference

Trending Topics in Gastroenterology

Explore current gastroenterology questions, clinical answers, and emerging research by topic.

101

Psychological interventions and IBD Management

Psychological interventions have been increasingly recognized as valuable components in the management of inflammatory bowel disease (IBD). This is because IBD is not only a physical condition but...

102

Therapy of iPSC-derived CD146+ mesenchymal stem cells in ulcerative colitis

The study explored the therapeutic potential of induced pluripotent stem cell-derived CD146+ mesenchymal stem cells (CD146+iMSCs) for treating ulcerative colitis (UC). These stem cells were compared to CD146+...

103

Decoding IBD progression

Decoding Inflammatory Bowel Disease (IBD) progression involves understanding how gut microbiota and host genetic changes correlate with disease severity. A recent study developed a multi-omics framework combining gut...

104

Ustekinumab trough level and perianal fistulizing Crohn’s disease

In the context of perianal fistulizing Crohn's disease (PFCD), ustekinumab (UST) trough concentrations play a critical role in predicting clinical and radiological remission. A recent study has identified...

105

Novel antibiotic targets IBD—and AI

The novel antibiotic targeting inflammatory bowel disease (IBD) is called enterololin, and it represents a groundbreaking achievement in medical research, combining cutting-edge artificial intelligence (AI) with pharmacological science....

106

Extended risankizumab treatment for Crohn’s disease

Extended risankizumab (RZB) therapy has shown promising results for Crohn’s disease patients who fail to respond to the standard 12-week induction phase. Phase 3 trials (ADVANCE, MOTIVATE, FORTIFY)...

107

Fidaxomicin and Crohn's Disease

Fidaxomicin has emerged as a promising therapeutic candidate for intestinal fibrosis in Crohn’s disease, a condition where up to 50% of patients develop strictures due to excessive collagen...

108

FACILE Classification: A New Era in IBD

The FACILE Classification represents a groundbreaking advancement in the way Inflammatory Bowel Disease (IBD), including Crohn's Disease (CD) and Ulcerative Colitis (UC), is categorized. Moving beyond traditional frameworks...

Previous
11011
Next
GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer